S. Roth

Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial

T. Rosen, N. Albareda, I. Zsolt, 2018, JAMA dermatology.

Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study.

S. Roth, B. Ekholm, E. Lee, 1990, Seminars in arthritis and rheumatism.

Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection

K. Naber, S. Roth, H. Lange, 1976, European Journal of Clinical Pharmacology.

Sisomicin: Serum Half-Life and Distribution Space in Patients with Normal and Impaired Renal Function

K. Naber, S. Roth, H. Lange, 1976 .

Auranofin: 1 mg or 9 mg? The search for the appropriate dose.

D. Saunders, S. Roth, D. Kaplan, 1982, The Journal of rheumatology. Supplement.

Efficacy and safety of sustained-release alfuzosin 5 mg in patients with benign prostatic hyperplasia. ALGEBI Study Group.

S. Roth, M. Delauche‐Cavallier, C. Geffriaud-Ricouard, 1997, European urology.

Therapeutic Phlebotomy in Patients with Grade 1 Hypertension: A Randomized-Controlled Trial.

A. Michalsen, T. Ostermann, R. Stange, 2022, Journal of integrative and complementary medicine.

Clinical uroselectivity: evidence from patients treated with slow-release alfuzosin for symptomatic benign prostatic obstruction.

S. Roth, M. Delauche‐Cavallier, C. Geffriaud-Ricouard, 1997, British journal of urology.